insights_auto
Why is INO up 16,43%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,63 $
arrow_upward
+16,43%(+0,23) 1D
1,67 $
arrow_upward
+2,45% (+0,040)bedtimeAfter hours
Closed: 17 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,38 $
High
1,64 $
Low
1,37 $
Mkt. cap
305,31 մլն
Avg. vol.
19,46 մլն
Volume
0,00
52-wk high
2,72 $
52-wk low
0,57 $
EPS
-0,80 $
Beta
1,71
Shares outstanding
187,31 մլն
No. of employees
112
Open
1,38 $
High
1,64 $
Low
1,37 $
Mkt. cap
305,31 մլն
Avg. vol.
19,46 մլն
Volume
0,00
52-wk high
2,72 $
52-wk low
0,57 $
EPS
-0,80 $
Beta
1,71
Shares outstanding
187,31 մլն
No. of employees
112
News stories
From web sources and news partners
Yahoo Finance
·
2 ժամ առաջ
Inovio Pharmaceuticals (INO) Stock Gets Fair Value Boost After VOCERYQ Approval
The Business Journals
·
17 ժամ առաջ
After 43 years, Inovio gets its first FDA-approved drug in 'milestone' decision
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc